I am currently Principal Scientist at Roche Sequencing Solutions, leading the efforts of new sequencing technology evaluation and development in Early Development. Before joining Roche, I trained as Postdoctoral Scholar with Dr. Michael Snyder in the Department of Genetics at Stanford University and was later Research Scientist in the Snyder lab. I have extensive experience in disease-related research and disease-orientated technology development, and am spearheading personalized health monitoring and preventative medicine with next-generation, high-throughput technologies. I orchestrated the first personalized health monitoring and preventative medicine proof-of-principle study with integrative omics, which was published as the only research paper in the 2012 special issue of Cell. This paper was later selected as “Genome Advance of the Month” by the National Human Genome Research Institute (National Institutes of Health), and also into Cell—Best of 2012. Beyond integrative personal omics research, I have broad expertise in cancer immunology and chemoresistance, and disease-related research such as asthma, Myelodysplastic Syndromes, as well as rare Mendelian diseases. I received my Ph.D. degree from Yale University in 2008 with the John Spangler Nicholas Prize, a prestigious award for most outstanding Ph.D. candidates in Biology.
Google Scholar Profile (Click Here)